share_log

AnPac Bio Announces Board and Management Changes,

AnPac Bio Announces Board and Management Changes,

Anpac Bio 宣佈董事會和管理層變動,
Benzinga Real-time News ·  2022/10/03 17:21
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) ("AnPac Bio" or the "Company"), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced changes to its board composition and management team.
在美國有業務、中國專注於癌症早期篩查和檢測的生物技術公司安派科股份有限公司(納斯達克股票代碼:ANPC)(以下簡稱:安派克生物)今天宣佈對其董事會組成和管理團隊進行變動。
Mr. Haohan Xu has been appointed as a director of the board of directors (the "Board"), Co-Chairperson of the Board and Co-Chief Executive Officer of the Company. Mr. Xu is the Chief Executive Officer of Apifiny Group Inc., a digital asset trading infrastructure provider based in New York, United States and has been actively engaged in the...
徐浩漢先生已獲委任為董事董事會(“董事會”)董事、董事會聯席主席及聯席行政總裁。徐先生是總部位於美國紐約的數位資產交易...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論